Loading...
•
Jul 31, 2024
HealthEquity Q2 2025 Earnings Report
HealthEquity's Q2 2025 financial results were released, showcasing revenue growth and increased profitability.
Key Takeaways
HealthEquity reported strong second-quarter results, with a 23% increase in revenue to $299.9 million and a significant rise in net income to $35.8 million. The company also announced a $300 million stock repurchase program.
Revenue increased by 23% year-over-year, reaching $299.9 million.
Net income rose to $35.8 million, a substantial increase from $10.6 million in the same quarter last year.
Non-GAAP net income increased by 67% to $76.3 million.
The company reported 9.4 million HSAs, a 15% increase compared to the previous year.
HealthEquity
HealthEquity
HealthEquity Revenue by Segment
Revenue by Segment
Service Revenue
CapyFin.comCustodial Revenue
CapyFin.comInterchange Revenue
CapyFin.com Forward Guidance
For the fiscal year ending January 31, 2025, HealthEquity expects revenue between $1.165 billion and $1.185 billion, net income between $94 million and $109 million, and Adjusted EBITDA between $458 million and $478 million.
Positive Outlook
- Revenue is expected to be between $1.165 billion and $1.185 billion.
- Net income is projected to be between $94 million and $109 million.
- Net income per diluted share is expected to be between $1.05 and $1.22.
- Non-GAAP net income is forecasted to be between $265 million and $280 million.
- Adjusted EBITDA is anticipated to be between $458 million and $478 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income